You are here
FDA Repeats Plavix Warning
"We are absolutely not" changing earlier warnings to doctors and patients against taking the drugs together, said Mary Ross Southworth, an FDA official overseeing the safety of cardiovascular products.
A series of studies since 2008 have indicated that the drug combination can cut in half Plavix's ability to prevent blood clots, according to the FDA. Earlier this month, however, a randomized trial called Cogent published in the New England Journal of Medicine suggested patients taking both drugs were at no greater risk of serious cardiovascular events than those taking Plavix alone.
The full story is available on the Wall Street Journal Web site.